Personal Injury Law

Eli Lilly suspends cancer study on safety concerns

By Hurley, McKenna & Mertz

Eli Lilly says it ?suspended a late-stage study of tasisulam as a potential skin cancer treatment because of safety concerns, but the company will continue studying the drug candidate in other cancer studies.? (Indianapolis AP, 12/13).

Although Lilly did not disclose any details of specific safety issues, the researchers were studying the drug?s ability to treat metastatic melanoma patients. Melanoma is the most common form of skin cancer.

Nonetheless, the company says it plans to continue to develop the drug ?as a potential treatment for breast, ovarian and other cancers, citing different dosing.?

As a Chicago medical malpractice attorney, I am hopeful that this drug will be, first and foremost, safe for use as a potential cancer treatment.

Full post as published by Chicago Medical Malpractice Lawyer Blog on December 21, 2010 (boomark / email).